ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Novasep, Lysogene Enter Gene Therapy Collaboration contractpharma
May 28, 2020?Novasep and Lysogene have entered an agreement for the development and manufacturing of LYS-GM101, an AAVrh10-based gene therapy drug candidate for the treatment of GM1 gangliosidosis, a rare neuronopathic lysosomal storage disorder.
Pharma Sources Insight July 2025
